000 | 03167nam a22004815i 4500 | ||
---|---|---|---|
001 | 978-1-61779-615-9 | ||
003 | DE-He213 | ||
005 | 20140220083251.0 | ||
007 | cr nn 008mamaa | ||
008 | 120403s2012 xxu| s |||| 0|eng d | ||
020 |
_a9781617796159 _9978-1-61779-615-9 |
||
024 | 7 |
_a10.1007/978-1-61779-615-9 _2doi |
|
050 | 4 | _aRB1-214 | |
072 | 7 |
_aMMF _2bicssc |
|
072 | 7 |
_aMED067000 _2bisacsh |
|
082 | 0 | 4 |
_a616.07 _223 |
100 | 1 |
_aBologna, Mauro. _eeditor. |
|
245 | 1 | 0 |
_aBiotargets of Cancer in Current Clinical Practice _h[electronic resource] / _cedited by Mauro Bologna. |
264 | 1 |
_aTotowa, NJ : _bHumana Press, _c2012. |
|
300 |
_aXVI, 563p. 100 illus., 57 illus. in color. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
490 | 1 | _aCurrent Clinical Pathology | |
505 | 0 | _aCentral Nervous System Tumors -- Head and Neck Tumors -- Thyroid Cancer -- Targeted Therapies for Non-Small Cell Lung Cancer -- Non-Hodgkin Lymphomas -- Leukemias -- Breast Cancer -- Esophago-Gastric Cancer -- Colorectal Cancer -- Hepatocellular Carcinoma -- Biomarkers for Prognosis and Molecularly Targeted Therapy in Renal Cell Carcinoma -- Bladder Cancer -- Biomarkers in Prostate cancer -- Ovarian Cancer -- Uterine Cancer: The Influence of Genetics and Environment on Cell Cycling Pathways in Cancer -- Biotargets in Sarcomas: The Past, Present and a Look into the Future -- Melanoma and other skin cancers -- Molecular pathology of cancer metastasis: suggestions for future therapy -- Current and future developments in cancer therapy research: miRNAs as new promising targets or tools. | |
520 | _aBiotargets of Cancer in Current Clinical Practice presents an updated and reasoned review of the current status of knowledge concerning the major cancer types with a special focus on the current biomarkers, genes involved and the potential future targets of innovative therapies. The volume includes for each major cancer type, a comprehensive although concise discussion of epidemiology, affirmed and innovative biomarkers for diagnosis, and descriptions of the relevant genes for prognosis and (individualized) therapy through biotarget-specific new molecular treatments, with the latest information on the validation status of each novel biomarker. Individual chapters are dedicated to the major cancer types, plus a special chapter on metastasis. The present debate on patentability of genetic information applied to diagnostics and therapeutics of cancer is also discussed. | ||
650 | 0 | _aMedicine. | |
650 | 0 | _aMedical laboratories. | |
650 | 0 | _aOncology. | |
650 | 0 | _aPathology. | |
650 | 1 | 4 | _aMedicine & Public Health. |
650 | 2 | 4 | _aPathology. |
650 | 2 | 4 | _aOncology. |
650 | 2 | 4 | _aLaboratory Medicine. |
710 | 2 | _aSpringerLink (Online service) | |
773 | 0 | _tSpringer eBooks | |
776 | 0 | 8 |
_iPrinted edition: _z9781617796142 |
830 | 0 | _aCurrent Clinical Pathology | |
856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-1-61779-615-9 |
912 | _aZDB-2-SME | ||
999 |
_c101612 _d101612 |